Скачать или смотреть How Vitamin D Impacts Diabetes and Metabolism.

In this episode, we discuss the role of Vitamin D in diabetes and metabolic syndrome. Our guest is Dr. Izabela Szymczak-Pajor, PhD, a researcher at the Medical University of Łódź | UMED, in the Department of Nucleic Acid Biochemistry.

We experienced some technical difficulties during the recording and apologize in advance for the audio issues in certain parts of the podcast. However, we didn’t want to miss the opportunity to share this valuable discussion.

We hope you enjoy the episode!

References:
-Szymczak-Pajor I, Drzewoski J, Śliwińska A. The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders. Int J Mol Sci. 2020 Sep 11;21(18):6644. doi: 10.3390/ijms21186644. PMID: 32932777; PMCID: PMC7554927.

-Szymczak-Pajor I, Śliwińska A. Analysis of Association between Vitamin D Deficiency and Insulin Resistance. Nutrients. 2019 Apr 6;11(4):794. doi: 10.3390/nu11040794. PMID: 30959886; PMCID: PMC6520736.

Timelapse:
00:00 Introduction
02:00 What sparked the interest in studying Vitamin D?
04:40 The role of Vitamin D supplementation in health
08:31 What changes occur at the molecular level?
11:47 The role of Vitamin D in adipose tissue
15:00 Vitamin D and its impact on DNA
20:30 Should Vitamin D be included in the treatment of diabetes and metabolic syndrome?
22:46 What’s next in research?

Follow me on social media:
Instagram:   / doctoref.rain  
Facebook:   / efrain.riverosperez  

Disclosure:
The content of this podcast is purely academic in nature and is intended for educational and informational purposes only. The material discussed does not represent or reflect the views, opinions, or policies of the Medical College of Georgia, and the information presented should not be construed as medical advice or guidance. Always consult with a qualified healthcare professional for any medical concerns or questions. I'd like to explicitly state that I have no endorsement from, affiliations with, or financial interests in any pharmaceutical companies or medical device manufacturers. Any mention of medications, devices, or treatments is made solely within the context of literature and academic discussion.